MXPA01005363A - 4'-substituido-4',5'-dihidropsoralen y usos terapeuticos del mismo. - Google Patents
4'-substituido-4',5'-dihidropsoralen y usos terapeuticos del mismo.Info
- Publication number
- MXPA01005363A MXPA01005363A MXPA01005363A MXPA01005363A MXPA01005363A MX PA01005363 A MXPA01005363 A MX PA01005363A MX PA01005363 A MXPA01005363 A MX PA01005363A MX PA01005363 A MXPA01005363 A MX PA01005363A MX PA01005363 A MXPA01005363 A MX PA01005363A
- Authority
- MX
- Mexico
- Prior art keywords
- substituted
- mammal
- aromatic ring
- nitrogen form
- heterocyclic aromatic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
La invencion se relaciona a compuestos 4-substituidos-4°, 5°-dihidropsoralen de la formula V. En la formula R es hidrogeno, un halogeno, CN o un grupo acilo; T es halogeno, CN, un grupo carboalcoxi NR1R2 o (N+R1R2R3)X-, R1 y R2 son independientemente un alquilo de C1-C6, o R1 y R2 junto con el nitrogeno forman un anillo heterociclico de 5-8 miembros o cuando T es (N+R1R2R3)X-, R1 y R2 junto con el nitrogeno forman un anillo heterociclico de 5-8 miembros o un anillo aromatico heterociclico; R3 es hidrogeno, un alquilo de C1-C12, o cuando R1 y R2 junto con el nitrogeno forman un anillo aromatico heterociclico, R3 es un doble enlace dentro del anillo aromatico heterociclico; X es haluro. En otra modalidad, la invencion se relaciona a procesos para preparar compuestos 4°-substituido-4°,5°-dihidropsoralen descritos anteriormente. Los compuestos de la invencion tienen propiedades farmaceuticas beneficas y pueden ser usados solos o en composiciones farmaceuticas usadas para tratar un trastorno proliferativo de la piel y para tratar infecciones microbianas en un mamifero al administrar al mamifero una cantidad efectiva de un compuesto de la invencion y despues se irradia el mamifero con luz ultravioleta.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11033698P | 1998-11-30 | 1998-11-30 | |
PCT/US1999/028174 WO2000032603A1 (en) | 1998-11-30 | 1999-11-30 | 4'-substituted-4',5'-dihydropsoralens and therapeutical uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA01005363A true MXPA01005363A (es) | 2004-04-21 |
Family
ID=22332461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA01005363A MXPA01005363A (es) | 1998-11-30 | 1999-11-30 | 4'-substituido-4',5'-dihidropsoralen y usos terapeuticos del mismo. |
Country Status (10)
Country | Link |
---|---|
US (1) | US6177424B1 (es) |
EP (1) | EP1144417B1 (es) |
AT (1) | ATE223418T1 (es) |
AU (1) | AU1925500A (es) |
CA (1) | CA2352258A1 (es) |
DE (1) | DE69902821T2 (es) |
ES (1) | ES2183636T3 (es) |
MX (1) | MXPA01005363A (es) |
PT (1) | PT1144417E (es) |
WO (1) | WO2000032603A1 (es) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4130568A (en) | 1976-09-14 | 1978-12-19 | Hoffmann-La Roche Inc. | 8-Methoxypsoralen derivatives |
US4124598A (en) | 1976-10-20 | 1978-11-07 | Hoffmann-La Roche Inc. | Psoralens |
US4196281A (en) * | 1976-10-20 | 1980-04-01 | Regents Of The University Of California | Psoralens |
US4294822A (en) | 1980-07-29 | 1981-10-13 | Thomas C. Elder, Inc. | 5-Aminoalkyl-4,4,8-trialkylpsoralens |
US4950770A (en) | 1987-06-16 | 1990-08-21 | Elder Pharmaceuticals, Inc. | Psoralens aminomethylation |
US5356929A (en) | 1989-01-23 | 1994-10-18 | Lehigh University | Reduced and quaternized psoralens as photo-activated therapeutics |
US5216176A (en) * | 1989-01-23 | 1993-06-01 | Lehigh University | 7-alkoxycoumarins, dihydropsoralens, and benzodipyranones as photo-activated therapeutic agents and inhibitors of epidermal growth factor |
US5712085A (en) | 1993-06-28 | 1998-01-27 | Cerus Corporation | 5'-(4-amino-2-oxa)butye-4,4', 8-trinethylpsoralen in synthetic medium |
US5399719A (en) | 1993-06-28 | 1995-03-21 | Steritech, Inc. | Compounds for the photodecontamination of pathogens in blood |
-
1999
- 1999-11-30 MX MXPA01005363A patent/MXPA01005363A/es unknown
- 1999-11-30 CA CA002352258A patent/CA2352258A1/en not_active Abandoned
- 1999-11-30 AU AU19255/00A patent/AU1925500A/en not_active Abandoned
- 1999-11-30 WO PCT/US1999/028174 patent/WO2000032603A1/en active IP Right Grant
- 1999-11-30 DE DE69902821T patent/DE69902821T2/de not_active Expired - Fee Related
- 1999-11-30 AT AT99962909T patent/ATE223418T1/de not_active IP Right Cessation
- 1999-11-30 PT PT99962909T patent/PT1144417E/pt unknown
- 1999-11-30 US US09/450,560 patent/US6177424B1/en not_active Expired - Fee Related
- 1999-11-30 EP EP99962909A patent/EP1144417B1/en not_active Expired - Lifetime
- 1999-11-30 ES ES99962909T patent/ES2183636T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6177424B1 (en) | 2001-01-23 |
DE69902821T2 (de) | 2003-01-09 |
ATE223418T1 (de) | 2002-09-15 |
AU1925500A (en) | 2000-06-19 |
WO2000032603A1 (en) | 2000-06-08 |
EP1144417A1 (en) | 2001-10-17 |
ES2183636T3 (es) | 2003-03-16 |
DE69902821D1 (de) | 2002-10-10 |
PT1144417E (pt) | 2002-12-31 |
EP1144417B1 (en) | 2002-09-04 |
CA2352258A1 (en) | 2000-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY25679A1 (es) | Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer | |
MY123354A (en) | 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives | |
FR2714378B1 (fr) | Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant. | |
BRPI0315188B8 (pt) | composto e composição farmacêutica | |
HUP0401646A2 (hu) | Tumorellenes hatású kinazolinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
TR200003478T2 (tr) | Antikanser maddeleri olarak faydalı izotiyazol türevleri | |
BG103947A (en) | Derivatives of 9-oxymerythromycin | |
AU2246292A (en) | Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
MXPA02001571A (es) | Metodo de tratamiento para el cancer. | |
AU6698894A (en) | 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
TW263513B (es) | ||
GB9727521D0 (en) | Substituted 2-benzylamino-2-phenyl-acetamide compounds | |
MXPA03000547A (es) | Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares. | |
BR0006299A (pt) | Derivados da 4-oxo-2-ureìdo-1,4,5,6-tetra-hidro-pirimidina | |
PL326554A1 (en) | Derivatives of amine and thiourea and inhibitors of nitrogen oxide synthase | |
AU695907B2 (en) | Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases | |
MXPA01005363A (es) | 4'-substituido-4',5'-dihidropsoralen y usos terapeuticos del mismo. | |
ITMI932193A1 (it) | Composti ad attivita' antiistaminica procedimento per la loro preperazione e composizioni farmaceutiche che li contengono. | |
AP9901559A0 (en) | Tricyclic 3-keto derivatives of 6-0-methylerythromycin. | |
ES2121058T3 (es) | Compuestos antibioticos de carbapenem. | |
EP1057829A4 (en) | Condensed pyrimidine derivatives and pharmaceutical compositions containing them | |
GEP20053513B (en) | 2-Aminocarbonyl-9H-Purine Derivatives | |
AU2932500A (en) | Compositions containing esters for treating parasitic infestations of organisms | |
MX9705379A (es) | Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora. |